Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Using Transcranial Magnetic Stimulation to Treat Neuropathic Pain from Spinal Cord Injuries

Official title: Efficacy of Repetitive Transcranial Magnetic Stimulation Therapy in Neuropathic Pain Associated With Spinal Cord Injury; Randomized Controlled Trial

Run by Afyonkarahisar Health Sciences University · NCT06726954 · Data updated 2026-11-12

This study is testing if a non-invasive brain treatment called rTMS can help reduce neuropathic pain and improve quality of life for people with spinal cord injuries.

More Neuropathic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment63 (estimated)
SponsorAfyonkarahisar Health Sciences University
Academic / other
Locations1 site (Afyonkarahisar)
StatusRecruiting
StartedDecember 16, 2024
Main results expectedSeptember 30, 2026
Study endsDecember 30, 2026
Registry record updatedJune 26, 2026
Trial IDNCT06726954 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-75 with a physician-diagnosed spinal cord injury and neuropathic pain lasting at least three months.

Probably not a fit

Patients with severe comorbid diseases, neurodegenerative disorders, or contraindications to TMS will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of high-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) therapy on neuropathic pain, depression, quality of life, and sleep in individuals with spinal cord injuries. Participants will undergo different rTMS protocols targeting either the dorsolateral prefrontal cortex or the primary motor cortex, alongside a placebo group. Initial assessments will include various questionnaires to evaluate pain and quality of life, with follow-up assessments conducted two months after treatment. The study aims to determine the efficacy of rTMS as a non-invasive treatment option for managing neuropathic pain.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce neuropathic pain and improve the overall quality of life for patients with spinal cord injuries.

How similar studies have gone: While there is evidence supporting the use of neuromodulation techniques for pain management, the specific application of rTMS in this context is still being explored and may represent a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Aged 18-75 years Physician-diagnosed spinal cord injury for at least 3-months Neuropathic pain for at least 3-months Pain not attributable to any other conditions

Exclusion Criteria:

* Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, uncontrolled hypertension,arrhythmia, pacemaker)
* Neurodegenerative disease
* Epilepsy
* History of antiepileptic drug use
* Cognitive dysfunction
* Lower extremity peripheral nerve injury
* Increased intracranial pressure or uncontrolled migraine
* Infection on the skin in the application area.
* Having a brain lesion or a history of drug use that will affect the seizure threshold.

Any TMS-related contraindications, for example:

* Pacemaker
* Metallic implant
* Previous seizure
* Psychiatric disorders (excluding depression and anxiety)
* Malignancy
* Current pregnancy

Where it's running

  • Afyonkarahisar Health Sciences University
    Afyonkarahisar, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Nuran Eyvaz, MD — Afyonkarahisar Health Sciences University
  • Study coordinator: Ayse Kalender, MD
  • Email: aysebuber007@gmail.com
  • Phone: +905389563559

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.